Recruiting
Phase 2

Evolocumab for PCSK9 Lowering in Early Acute Sepsis (The PLEASe Study)

Sponsor:

University of British Columbia

Code:

NCT03869073

Conditions

Sepsis

Eligibility Criteria

Sex: All

Age: 19+

Healthy Volunteers: Not accepted

Interventions

Evolocumab

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information